Weekly Market Roundup
Boundless Bio Stock Up 87% on Failed Drug and Reverse Merger Deal
Boundless Bio’s cancer drug did not work. The company is cutting three-quarters of its staff. Its stock went up 87%. Boundless Bio Hands Control to a Private Gene-Editing Startup After Its Lead Drug Fails On June 22, Boundless Bio (Nasdaq: BOLD) signed a definitive merger agreement with Serapha Bio, a privately held company developing a…
Newcore Gold Falls 24% on Enchi PFS as Luca and Faraday Post Results
The press release said “robust.” The stock fell 24% to its lowest level in 17 months. Newcore Gold Headlines Spot-Price Economics While the Base Case Disappoints Newcore Gold (TSX-V: NCAU / OTCQX: NCAUF) released a pre-feasibility study for its Enchi Gold Project in Ghana on June 24. The headline numbers: an after-tax net present value…
Bitmine Raises $273.8M for ETH as Sezzle Jumps on Fragile Iran Deal
Sezzle jumped 10.1% on June 15 because a deal in Switzerland promised to reopen the Strait of Hormuz. By June 18, Iran had closed it again. Bitmine Raises $273.8 Million in Preferred Stock to Buy More Ethereum While Diluting Shareholders 213-Fold Bitmine Immersion Technologies (NYSE: BMNR) announced on June 15 that its total crypto, cash,…
Eos Energy Up 12% on Battery Line 2 as Brenmiller Eyes Italy Market
Eos Energy’s stock is down 52% over six months. On June 16, it jumped 12% in a single morning. Eos Energy Launches Battery Line 2 and Stock Jumps 12% Despite Being Down 52% Over Six Months Eos Energy Enterprises (Nasdaq: EOSE) announced on June 16 that it had started commercial production on Battery Line 2…
Intel Surges 10% After Trump Confirms Apple Chip Deal as Accenture Drops 13% on Guidance Cut
Intel’s 18A node packs 238 million transistors per square millimeter. TSMC’s competing N2 node packs 313 million. On June 18, Apple agreed to use Intel anyway, just not for the chips that matter most yet. Intel Surges After Trump Confirms Apple Will Use Intel Foundry for US-Made Chips President Trump posted on Truth Social early…
Pancreatic Cancer Trial Ahead of Schedule, Gastric Cancer Fast Track Win
A drug called givastomig produced a 77% response rate in gastric cancer. The stock trades 71% below its 52-week high. Sometimes the data and the price tell two different stories. AIM ImmunoTech Doses Final Patient in Phase 2 Pancreatic Cancer Trial Ahead of Schedule AIM ImmunoTech (NYSE American: AIM) had a busy stretch in the…
Banyan Gold 62.66 g/t Yukon Find and Formation Metals N2 Extension
Gold averaged $3,300 an ounce this month. At a 0.30 g/t cutoff, that turns marginal rock into ore. Banyan Gold just drilled 62.66 grams per tonne. That is not marginal rock. Banyan Gold Intersects 62.66 g/t Gold in a New High-Grade Zone at the Powerline Deposit, Yukon Banyan Gold Corp. (TSXV: BYN / OTCQB: BYAGF)…
Hut 8 Closes $4.25B AI Bond and Coinbase Launches Crypto Agents
Bitcoin mining companies used to fund themselves by selling the coins they dug up. Hut 8 just raised $4.25 billion in bonds. These are not the same business model. Hut 8 Closes $4.25 Billion Texas AI Data Center Bond and Appoints Stanley O’Neal as Chairman On June 10, Hut 8 Corp. (Nasdaq: HUT) closed a…
374Water PFAS Capacity Upgrade and PureCycle Packaging Milestone
PFAS has been detected in the blood of 97% of Americans. It does not biodegrade. Most technologies capture it, concentrate it, or move it somewhere else. 374Water’s technology destroys it permanently. On June 9, the company upgraded the facility that does that. 374Water Expands Iron Bridge Facility Targeting $3 Million to $5 Million in Annual…
Siri Gets Rebuilt, SpaceX Goes Public: The Week That Changed AI Markets
Siri has been the butt of the joke for five years. On June 8, Apple spent $1 billion to fix that. Apple WWDC 2026 Reveals Siri AI Powered by Custom 1.2 Trillion Parameter Gemini Model Apple’s Worldwide Developers Conference opened June 8 at Apple Park. The keynote landed with a specific number: 1.2 trillion parameters.…
